APA (7th ed.) Citation

P, D., I, S., G, F., R, L., L, P., J, B., . . . PF, T. (1998). Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16(2), 453. https://doi.org/10.1200/JCO.1998.16.2.453

Chicago Style (17th ed.) Citation

P, Dombernowsky, et al. "Letrozole, a New Oral Aromatase Inhibitor for Advanced Breast Cancer: Double-blind Randomized Trial Showing a Dose Effect and Improved Efficacy and Tolerability Compared with Megestrol Acetate." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 16, no. 2 (1998): 453. https://doi.org/10.1200/JCO.1998.16.2.453.

MLA (9th ed.) Citation

P, Dombernowsky, et al. "Letrozole, a New Oral Aromatase Inhibitor for Advanced Breast Cancer: Double-blind Randomized Trial Showing a Dose Effect and Improved Efficacy and Tolerability Compared with Megestrol Acetate." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 16, no. 2, 1998, p. 453, https://doi.org/10.1200/JCO.1998.16.2.453.